Accendra Health Inc (ACCH) stock
Price, market cap and P/E appear here once daily prices are connected.
Accendra Health Inc saw revenue fall 7.1% to $2.55B over the twelve months to Sep 30, 2026. Free cash flow was -$199.12M. At the latest close the market valued the company at $10.00M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $10.00M
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -1991.66%
Fundamentals
- Revenue
- $2.55B
- Net income
- -$171.56M
- EPS, diluted
- -$2.23
- Free cash flow
- -$199.12M
- Book value per share
- -$7.39
- Diluted shares
- 77M
Trading
- 52-week range
- $0.12 – $4.69
- RSI (14 days)
- 22.7
- Volatility (1 year)
- 112.7%
- Relative volume
- 0.94×
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Accendra Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Update
- Update
About Accendra Health
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Accendra Health, Inc. provides medical supplies, technology, and home healthcare equipment across the United States. Its offerings focus on home respiratory therapy, obstructive sleep apnea treatment, diabetes care, wound care, and ostomy supplies. The company also delivers clinical support and patient management services designed to facilitate medical treatment outside acute care facilities. It operates primarily under brands such as Apria and Byram Healthcare, distributing products directly to individual patients as well as home health agencies. Reimbursement and payment arrangements involve commercial health insurers, managed care plans, state Medicaid programs, federal Medicare coverage, and direct out-of-pocket patient payments.
Company profile, executives and historyAccendra Health stock: common questions
What is ACCH's P/E ratio?
Accendra Health lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.23), so it has no meaningful P/E ratio.
How much revenue does Accendra Health make?
Accendra Health reported revenue of $2.55B for the twelve months to Sep 30, 2026, down 7.1% from a year earlier.
Does Accendra Health pay a dividend?
No. Accendra Health has not paid a cash dividend over the last twelve months.
How many ACCH shares are sold short?
10M shares were sold short at the latest FINRA report, 16.68% of the float, or 4.0 days of average trading volume.
Who are Accendra Health's competitors?
Companies most similar to Accendra Health by business, industry and size include HSIC, PLUS, AHCO, CNXN, SCSC.
See a number that looks wrong?